...
首页> 外文期刊>Chembiochem: A European journal of chemical biology >Chemoenzymatic Synthesis of Biotinylated Nucleotide Sugars as Substrates for Glycosyltransferases
【24h】

Chemoenzymatic Synthesis of Biotinylated Nucleotide Sugars as Substrates for Glycosyltransferases

机译:化学酶法合成生物素化核苷酸糖作为糖基转移酶的底物

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

The enzymatic oxidation of uridine 5'-diphospho-#alpha#-D-galactose (UDP-Gal) and uridine 5'-diphospho-N-acetyl-#alpha#-D-galactosamine (UDP-GalNAc) with galactose oxidase was combined with a chemical biotinylation step involving biotin-#edsilon#-amidocaproylhydrazino-#alpha#-D-galactose (UDP-6-biotinyl-Gal) and uridine 5'-diphospho-6-biotin-#edsilon#-amidocaproylhydrazino-N-acetyl-#alpha#-D-galactose (UDP-6-biotinyl-GalNAc) were synthesized on a 100-mg scale and characterized by mass spectrometry (fast atom bombardment and matrix-assisted laser desorption/ionization time of flight) and one/two dimensional NMR spectroscopy. It could be demonstrated for the first time, by use of UDP-6-biotinyl-Gal as a donor substrate, that the human recombinant galactosyltransferases #beta#3Gal-T5, #beta#4Gal-T1, and #beta#4Gal-T4 meidate biotinylation of the neoglycocon-jugate bovine serum albumin -p-aminophenyl N-acetyl-#beta#-D-glucosaminide (BSA-(GicNAc)_(17)) and ovalbumin. The detection of the biotin tag transferred by #beta#3Gal-T5 onto BSA-(GicNAc)_(17) with streptavidin-enzyme conjugates gave detection limits of 150 pmol of tagged GICNAc in a Western blot analysis and 1 pmol of tagged GicNAc in a microtiter plate assay. The dagree of Gal-biotin tag transfer onto agalactosylated hybrid N-glycans present at the single glycosylation site of ovalbumin was dependent on the Gal-T used (either #beta#3Gal-T5, #beta#4Gal-T4, or #beta#4Gal-T1), which indicates that the acceptor specificity may direct the transfer of the Gal-biotin tag. The potential of this biotinylated UDP-Gal as a novel donor substrate for human galactosyltransferases lies in the targeting of distinct acceptor structures, for example, under-galactosylated glycoconjgates, which are related to diseases, or in the quality glycoconjugates, which are related to diseases, or in the quality control of glycosylation of recombinant and native glycoproteins.
机译:结合尿嘧啶5'-二磷酸-#alpha#-D-半乳糖(UDP-Gal)和尿苷5'-二磷酸-N-乙酰基-#alpha#-D-半乳糖胺(UDP-GalNAc)的酶氧化化学生物素化步骤,包括生物素-#edsilon#-酰胺基丙烯酰肼基-α-D-D-半乳糖(UDP-6-生物素-Gal)和尿苷5'-二磷酸-6-生物素-#edsilon#-酰胺基丙烯酰肼基-N-乙酰基-#alpha#-D-半乳糖(UDP-6-生物素-GalNAc)的合成规模为100 mg,并通过质谱(快速原子轰击和基质辅助激光解吸/电离飞行时间)和一/两个进行表征NMR光谱学。通过使用UDP-6-生物素-Gal作为供体底物,人类重组半乳糖基转移酶#beta#3Gal-T5,#beta#4Gal-T1和#beta#4Gal-T4首次得到证明。新糖偶联物牛血清白蛋白-对氨基苯基N-乙酰基-β-β-D-氨基葡萄糖苷(BSA-(GicNAc)_(17))和卵清蛋白的明代生物素化。用链霉亲和素-酶结合物检测由#beta#3Gal-T5转移到BSA-(GicNAc)_(17)上的生物素标签,在蛋白质印迹分析中检测极限为150 pmol标记的GICNAc,而在p53中为1 pmol标记的GicNAc。微量滴定板分析。 Gal-生物素标签转移到卵清蛋白单个糖基化位点上的半乳糖基化杂化N-聚糖上的转移程度取决于所用的Gal-T(#beta#3Gal-T5,#beta#4Gal-T4或#beta# 4Gal-T1),这表明受体特异性可以指导Gal-生物素标签的转移。这种生物素化的UDP-Gal作为人类半乳糖基转移酶的新型供体底物的潜力在于靶向不同的受体结构,例如与疾病相关的半乳糖基化糖基结合物,或与疾病相关的优质糖缀合物。 ,或用于重组和天然糖蛋白糖基化的质量控制。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号